Washington Post: A coronavirus vaccine can’t come at the expense of fighting the virus now, by Prof. Robin Scheffler
Jul 24, 2020
A coronavirus vaccine can’t come at the expense of fighting the virus now
Government investment in a cancer vaccine had drawbacks
by Prof. Robin Scheffler
The ink is still drying on a $1.95 billion deal between the United States and Pfizer to deliver 100 million doses of an experimental coronavirus vaccine to Americans as soon as this winter. The contract is the largest awarded by “Operation Warp Speed,” the Trump administration’s ambitious plan to accelerate the production of a vaccine, and arrives on the heels of billions of dollars channeled to other pharmaceutical firms.